Society for Immunotherapy of Cancer (SITC)

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.

Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.

Mission:
It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through their core values of interaction/integration, innovation, translation and leadership in the field. Core Values:
• Interaction/Integration: :Facilitate the exchange of information and education among basic and translational researchers, clinicians, young investigators, societies and groups sharing the mission of SITC • Innovation: :Challenge the thinking and seek the best research in the development of cancer immunotherapy • Translation: :Facilitate the transfer of cancer immunology and immunotherapy research from the bench to the clinic and back • Leadership: :Define what is new and important and effectively communicate it to all relevant stakeholders